《中医药单用/联合抗生素治疗常见感染性疾病临床实践指南·脓毒症》临床应用评价与修订意见  

Clinical application evaluation and revision suggestions of clinical practice guideline on traditional Chinese medicine therapy alone or combined with antibiotics for sepsis

作　　者：张瑞 陈奕杉[1,2] 赵国桢 王东东 哈雁翔[1,2] 黄坡 胡晶 冯硕 郭玉红 廖星 谢雁鸣 张俊华[4] 张伯礼[4] 李博[1] 刘清泉[1] ZHANG Rui;CHEN Yi-shan;ZHAO Guo-zhen;WANG Dong-dong;HA Yan-xiang;HUANG Po;HU Jing;FENG Shuo;GUO Yu-hong;LIAO Xing;XIE Yan-ming;ZHANG Jun-hua;ZHANG Bo-li;LI Bo;LIU Qing-quan(Beijing Institute of Traditional Chinese Medicine,Beijing Hospital of Traditional Chinese Medicine,Capital Medical University,Beijing 100010,China;Beijing University of Chinese Medical,Beijing 100029,China;Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Tianjin University of Traditional Chinese Medicine,Tianjin 300193,China)

机构地区：[1]首都医科大学附属北京中医医院北京市中医研究所,北京100010 [2]北京中医药大学,北京100029 [3]中国中医科学院中医临床基础医学研究所,北京100700 [4]天津中医药大学,天津300193

出　　处：《中国中药杂志》2018年第24期4776-4781,共6页China Journal of Chinese Materia Medica

基　　金：中央级公益性科研院所基本科研业务费专项(ZZ10-018-02,ZZ11-021,Z0546);国家自然科学基金项目(81774146);北京市属医学科研院所科技发展项目(PXM2017_026273_000003)

摘　　要：调查我国临床医生对《中医药单用/联合抗生素治疗常见感染性疾病临床实践指南·脓毒症》的临床应用情况,以促进该《指南》的后续修订和进一步推广。应用评价调查问卷和适用评价调查问卷均采用记名问卷方法,向我国使用过该《指南》的临床医师各投放500份;采用Excel 2016建立数据库,进行描述性统计分析。应用性评价调查问卷和适用性评价调查问卷各回收211份。该调查得出结论:在现有推荐方案评价较好的基础上,针对整体内容、整体结构上再做调整;对推荐方案的方剂选择、临床证据进行更新;对《指南》应用过程中的阻碍因素提出改善措施,同时为了更好更明确地推广,应加强医患教育,提高指南质量,增大宣传力度,为《指南》的实施推广策略提供依据。To investigate the clinical application of clinical practice guideline on traditional Chinese medicine therapy alone or combined with antibiotics for sepsis,in order to promote the follow-up revision and further promotion of the Guidelines. Copies of 500 application evaluation questionnaire and 500 copies of applicability evaluation questionnaire were given to the clinicians who had used this Guideline in China,both in a form of registered questionnaire,and a database was established by Excel 2016 for descriptive statistical analysis. Copies of 211 application evaluation questionnaire and 211 copies of applicability evaluation questionnaire were collected. We can conclude from the survey that we should adjust the whole content and structure on the basis of better evaluation of the present recommendation scheme,update the prescription selection and clinical evidence of the recommendation scheme,and put forward the improvement measures for the hindrance factors in the application of the Guideline. Furthermore,in order to promote the Guideline more clearly,we should strengthen the doctor-patient education,improve guidance quality and increase the publicity,providing basis for the implementation and promotion strategies of the Guideline.

关 键 词：脓毒症 临床实践指南 应用评价 

分 类 号：R51[医药卫生—内科学]